Position in TWST
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$326,026
-$460,478 QoQ
Shares Held
3,169
-81.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#221
of 334 holders
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TWST Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $550,105,949 across 22 Diagnostics & Research names. TWST ranks #20 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
433,146 | $98,233,181 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
139,499 | $69,939,218 | |
| 3 | ILMN |
Illumina, Inc.
|
356,183 | $62,627,656 | |
| 4 | DHR |
Danaher Corp /De/
|
235,913 | $44,936,708 | |
| 5 | SHC |
Sotera Health Co
|
2,206,457 | $39,164,611 | |
| 6 | A |
Agilent Technologies, Inc.
|
256,435 | $34,062,261 | |
| 7 | NTRA |
Natera, Inc.
|
102,398 | $27,795,937 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
140,692 | $27,184,508 |
All Filings in TWST
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $326,026 | 3,169 | Shares | Sole | 2026-08-14 | |
| 2024-12-31 | $786,504 | 16,925 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,253,202 | 27,738 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,895,682 | 79,052 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,088,518 | 60,872 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,030,211 | 55,079 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $863,035 | 42,598 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $246,768 | 12,061 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||